Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
What is Vector Science and Therapeutics Quick Ratio?
Vector Science and TherapeuticsTSXV:PAIN -4.32%14 Quick Ratio is 20.79 as of Feb. 2026, which is 76% above its 10-year median of 11.82. GuruFocus rates TSXV:PAIN with a GF Score™ of 14/100. Among 853 Medical Devices & Instruments companies, Vector Science and Therapeutics ranks better than 98.24% on this metric.
Vector Science and Therapeutics has a quick ratio of 20.79. It generally indicates good short-term financial strength.
The historical rank and industry rank for Vector Science and Therapeutics's Quick Ratio or its related term are showing as below:
TSXV:PAIN'
s Quick Ratio Range Over the Past 10 Years
Min: 7.16 Med: 11.82 Max: 20.79
Current: 20.79
During the past 2 years, Vector Science and Therapeutics's highest Quick Ratio was 20.79. The lowest was 7.16. And the median was 11.82.
TSXV:PAIN's Quick Ratio is ranked better than 98.24% of 853
companies
in the Medical Devices & Instruments industry
Industry Median: 1.89
vs TSXV:PAIN: 20.79
Vector Science and Therapeutics (TSXV:PAIN) Quick Ratio Explanation
The quick ratio is more conservative than the Current Ratio because it excludes inventories from current assets. The ratio derives its name presumably from the fact that assets such as cash and marketable securities are quick sources of cash. Inventories generally take time to be converted into cash, and if they have to be sold quickly, the company may have to accept a lower price than book value of these inventories. As a result, they are justifiably excluded from assets that are ready sources of immediate cash.
In general, low or decreasing quick ratios generally suggest that a company is over-leveraged, struggling to maintain or grow sales, paying bills too quickly or collecting receivables too slowly. On the other hand, a high or increasing quick ratio generally indicates that a company is experiencing solid top-line growth, quickly converting receivables into cash, and easily able to cover its financial obligations. Such companies often have faster inventory turnover and cash conversion cycles.
The higher the quick ratio, the better the company's liquidity position.
Vector Science and Therapeutics Quick Ratio Related Terms
Vector Science and Therapeutics Quick Ratio Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Vector Science and Therapeutics Quick Ratio Chart
Vector Science and Therapeutics Annual Data
Trend
Aug24
Aug25
Quick Ratio
0.00
11.82
Vector Science and Therapeutics Quarterly Data
Aug24
Nov24
Aug25
Nov25
Feb26
Quick Ratio
0.00
0.00
11.82
7.16
20.79
TSXV:PAIN vs ABT, SYK, MDT: Quick Ratio Comparison
For the Medical Devices subindustry, Vector Science and Therapeutics's Quick Ratio, along with its competitors' market caps and Quick Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Vector Science and Therapeutics Quick Ratio vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Vector Science and Therapeutics's Quick Ratio distribution charts can be found below:
* The bar in red indicates where Vector Science and Therapeutics's Quick Ratio falls into.
Vector Science and Therapeutics Quick Ratio Calculation
The quick ratio measures a company's ability to meet its short-term obligations with its most liquid assets. For this reason, the ratio excludes inventories from current assets.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Vector Science and Therapeutics (TSXV:PAIN) has a Quick Ratio of 20.79 as of Feb. 2026. Quick ratio is the ratio of current assets less inventory to current liabilities. View historical data on Vector Science and Therapeutics and its competitors. This is 76% above median its historical median of 11.82. Over the past decade, Vector Science and Therapeutics' Quick Ratio has ranged from 7.16 to 20.79. According to the industry distribution chart, Vector Science and Therapeutics ranks #15 out of 853 companies in the Medical Devices & Instruments industry, placing it in the top 1.8%.
Is Vector Science and Therapeutics' Quick Ratio too high?
Vector Science and Therapeutics' current Quick Ratio of 20.79 is 76% above median its 10-year median of 11.82. Over the past 10 years, this metric has ranged from a low of 7.16 to a high of 20.79. The Medical Devices & Instruments industry median Quick Ratio is 1.89. Vector Science and Therapeutics' value of 20.79 is 1000% above this industry median. Based on the distribution chart, Vector Science and Therapeutics ranks #15 out of 853 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Vector Science and Therapeutics has a GF Score™ of 14/100, reflecting its overall financial health beyond just this single metric.
How does Vector Science and Therapeutics' Quick Ratio compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Vector Science and Therapeutics ranks #15 out of 853 companies for Quick Ratio. This places Vector Science and Therapeutics in the top 2% of its industry — outperforming the majority of peers. The industry median Quick Ratio is 1.89. Vector Science and Therapeutics' value of 20.79 is 1000% above this benchmark. Historically, Vector Science and Therapeutics' own Quick Ratio has ranged from 7.16 to 20.79 over the past decade. While the company's 10-year median is 11.82 vs. the industry median of 1.89, Vector Science and Therapeutics has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Quick Ratio for a Medical Devices & Instruments company?
The median Quick Ratio among Medical Devices & Instruments companies is 1.89, based on 853 companies in the industry. Companies in the top quartile (top 25%) have a Quick Ratio significantly above this median, while those in the bottom quartile fall well below. However, Quick Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Vector Science and Therapeutics's current Quick Ratio of 20.79 is 1000% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Quick Ratio mean?
A high Quick Ratio can signal that a stock is expensive relative to its fundamentals. Quick ratio is the ratio of current assets less inventory to current liabilities. View historical data on Vector Science and Therapeutics and its competitors. For the Medical Devices & Instruments industry, the median Quick Ratio is 1.89 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Vector Science and Therapeutics's current Quick Ratio is 20.79, which is 76% above median its own 10-year median of 11.82. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Vector Science and Therapeutics stock overvalued right now?
Vector Science and Therapeutics (TSXV:PAIN) has a current Quick Ratio of 20.79. The current Quick Ratio is 20.79, which is 76% above median its 10-year median of 11.82 and 1000% above the Medical Devices & Instruments industry median of 1.89. Vector Science and Therapeutics' overall GF Score™ is 14/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Quick Ratio calculated?
Quick Ratio is calculated from a company's financial statements. For Vector Science and Therapeutics (TSXV:PAIN), the current Quick Ratio is 20.79 as of Feb. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Vector Science and Therapeutics Business Description
Vector Science and Therapeutics Corp develops novel biomechanical devices and active transdermal drug and peptide delivery platforms to equip clinicians with non-systemic, localized interventions targeting a broad cross-section of diseases and conditions where systemic delivery of interventions compromises the therapeutic effect or introduces unacceptable harm.
14GF Score
Get the complete analysis for TSXV:PAIN
Quick Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSXV:PAIN has been successfully added to your 
